NeuroOne Medical Technologies Corp
NASDAQ:NMTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NeuroOne Medical Technologies Corp
NASDAQ:NMTC
|
US |
|
A
|
Antofagasta PLC
XMUN:FG1
|
UK |
|
Breakthrough Minerals Ltd
ASX:BTM
|
AU |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
F
|
Fresenius SE & Co KGaA
F:FRE
|
DE |
|
R
|
Reach PLC
F:MRR
|
UK |
|
F
|
F5 Inc
XMUN:FFV
|
US |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
Bleecker SA
PAR:BLEE
|
FR |
|
B
|
Baidu Inc
XMUN:B1CB
|
CN |
|
Altitude Minerals Ltd
ASX:ATT
|
AU |
|
T
|
TDSPharm Co Ltd
KOSDAQ:464280
|
KR |
|
R
|
Rockworth PCL
SET:ROCK
|
TH |
|
Reliance Worldwide Corporation Ltd
F:0EU
|
AU |
Intrinsic Value
Is NMTC undervalued or overvalued?
See the intrinsic value estimate for
NeuroOne Medical Technologies Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What NeuroOne Medical Technologies Does
NeuroOne Medical Technologies makes medical devices used by doctors who treat and study the brain and nervous system. Its products are sold mainly to hospitals, surgery centers, and neurologists that need tools for brain mapping, epilepsy testing, and other procedures involving electrical signals from the brain and nerves.
- Headquarters
- United States of America US
- Employees
- 18
- IPO date
- Nov 9, 2012
Revenue & Expenses Breakdown
NeuroOne Medical Technologies Corp
Earnings Waterfall
NeuroOne Medical Technologies Corp
The intrinsic value for
NeuroOne Medical Technologies Corp (NMTC) under the Base Case is hidden USD.
Compared with the current market price of 0.89745 USD, the stock appears hidden.